Cargando…

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

BACKGROUND: HER2-low breast cancers were reported to have distinct clinicopathological characteristics from HER2-zero; however, the difference in their genetic features remains unclear. This study investigated the clinical and molecular features of breast tumors according to HER2 status. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guochun, Ren, Chongyang, Li, Cheukfai, Wang, Yulei, Chen, Bo, Wen, Lingzhu, Jia, Minghan, Li, Kai, Mok, Hsiaopei, Cao, Li, Chen, Xiaoqing, Lin, Jiali, Wei, Guangnan, Li, Yingzhi, Zhang, Yuchen, Balch, Charles M., Liao, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052533/ https://www.ncbi.nlm.nih.gov/pubmed/35484593 http://dx.doi.org/10.1186/s12916-022-02346-9

Ejemplares similares

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing
por: Jia, Minghan, et al.
Publicado: (2021)

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients
por: Wen, Lingzhu, et al.
Publicado: (2021)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
por: Li, Kai, et al.
Publicado: (2020)

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours
por: Chen, Bo, et al.
Publicado: (2021)

Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature
por: Li, Cheukfai, et al.
Publicado: (2022)

Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations
por: Li, Kai, et al.
Publicado: (2022)

Association of Body Mass Index With Somatic Mutations in Breast Cancer
por: Chen, Bo, et al.
Publicado: (2021)

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis
por: Li, Cheukfai, et al.
Publicado: (2022)

Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer
por: Lai, Jianguo, et al.
Publicado: (2019)

Comprehensive analysis of autophagy‐related prognostic genes in breast cancer
por: Lai, Jianguo, et al.
Publicado: (2020)

Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer
por: Zhu, Wenzhen, et al.
Publicado: (2020)

Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature
por: Lai, Jianguo, et al.
Publicado: (2020)

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
por: Zhang, Yuchen, et al.
Publicado: (2022)

Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer
por: Wang, Yulei, et al.
Publicado: (2020)

GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
por: Zhang, Guochun, et al.
Publicado: (2019)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2021)

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics
por: Xiao, Weikai, et al.
Publicado: (2021)

CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients
por: Lai, Jianguo, et al.
Publicado: (2021)

Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern
por: Li, Ying-Zi, et al.
Publicado: (2022)

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study
por: Lin, Xiaoyi, et al.
Publicado: (2021)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study
por: Liu, Rongrui, et al.
Publicado: (2021)

Expression of a novel splice variant of FRMD7 in developing human fetal brains that is upregulated upon the differentiation of NT2 cells
por: LI, YINGZHI, et al.
Publicado: (2014)

Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
por: Shen, Wen-Qian, et al.
Publicado: (2022)

Single-cell transcriptome sequencing revealing the difference in photosynthesis and carbohydrate metabolism between epidermal cells and non-epidermal cells of Gracilariopsis lemaneiformis (Rhodophyta)
por: Chen, Haihong, et al.
Publicado: (2022)

MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1
por: Yu, Weixuan, et al.
Publicado: (2019)

Expression and localization of FRMD7 in human fetal brain, and a role for F-actin
por: Pu, Jiali, et al.
Publicado: (2011)

Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency
por: Chen, Zixi, et al.
Publicado: (2020)

Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer
por: Lin, Xiaoyi, et al.
Publicado: (2022)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis
por: Lin, Xiao-Yi, et al.
Publicado: (2023)

Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer
por: Quan, Xueping, et al.
Publicado: (2018)

Somatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal Nevi
por: Levinsohn, Jonathan L., et al.
Publicado: (2013)

Distinct Epidermal Keratinocytes Respond to Extremely Low-Frequency Electromagnetic Fields Differently
por: Huang, Chao-Ying, et al.
Publicado: (2014)

Distinct Somatic Discrimination Reflected by Laser-Evoked Potentials Using Scalp EEG Leads
por: Hsueh, Jen-Jui, et al.
Publicado: (2016)

Association of candidate single nucleotide polymorphisms with somatic mutation of the epidermal growth factor receptor pathway
por: Wormald, Samuel, et al.
Publicado: (2013)

Whole exome sequencing of multiple meningiomas with varying histopathological presentation in one patient revealed distinctive somatic mutation burden and independent clonal origins
por: Sheng, Han-Song, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ed2puqmc2pn3ct0kd6tgcu9m3i